MJardin Group Receives Its First Cannabis Sales License from Health Canada

Sales License to Accelerate Cannabis Sales and Deliver Supply to
Canadian Market

DENVER–(BUSINESS WIRE)–MJardin Group, Inc. (“MJardin” or the “Company”)
(CSE:MJAR), a leader in cannabis management, today announced that its
WILL cultivation facility in Brampton, Ontario has received its first
license to sell cannabis under the Cannabis Act (Canada), which went
into effect on October 17, 2018.

The license allows MJardin to supply and sell finished cannabis products
to provincial governments throughout Canada and through Canada’s
distribution and retail supply chain. The 32,800 square foot facility
has a current production capacity of 3,000 kg per year and MJardin has
plans to expand WILL’s existing facility and increase total production
capacity to over 5,000 kg per year.

“Our first sales license in Canada is a key development for MJardin and
a testament to the experience of our team and our ability to efficiently
execute our business strategy in the markets we enter,” said Rishi
Gautam, Chairman and Chief Executive Officer of MJardin. “The Canadian
cannabis market is facing severe supply shortages due to strong consumer
demand throughout the country. This license will accelerate MJardin’s
sales in Canada and allow us to deliver significant supply to the market
to meet growing demand for high quality medicinal and adult-use cannabis
products.”

Earlier this month, MJardin announced that its cultivation and
extraction facility in Lower Sackville, Nova Scotia owned by AtlantiCann
Medical Inc., in which MJardin has a 50% equity interest, was granted a
license by Health Canada for cannabis cultivation. The new
state-of-the-art, 48,000 square foot cultivation and extraction facility
has a production capacity of 6,000 kg per year, with expansion planned
for an additional 20,000 square feet by the end of 2019.

About MJardin Group

MJardin is a global cannabis management platform with extensive
experience in cultivation, processing, distribution and retail. For over
10 years, MJardin has refined cultivation methodologies, developed
state-of-the-art facilities and implemented vertical integration for and
on behalf of license owners. As a well-capitalized organization, MJardin
continues to pursue strategic expansion and M&A opportunities across
global legal cannabis markets. MJardin is based in Denver, Colorado,
with offices in Toronto, Canada and Barcelona, Spain. For more
information, please visit www.mjardin.com.

The CSE has not in any way passed upon the merits of and has neither
approved nor disapproved the contents of this news release.

This news release does not constitute an offer to sell or a
solicitation of an offer to sell any of the securities in the United
States. The securities have not been and will not be registered under
the United States Securities Act of 1933, as amended (the “U.S.
Securities Act”) or any state securities laws and may not be offered
or sold within the United States or to U.S. Persons unless registered
under the U.S. Securities Act and applicable state securities laws or an
exemption from such registration is available.

Forward-Looking Information

This news release contains forward-looking information based on
current expectations. Statements about, among other things, future
developments and the business and operations of MJardin, the cannabis
sales license discussed in this press release, the growth of or global
footprint and our intentions to leverage our scale for continued organic
growth and to pursue strategic investments are all forward-looking
information. These statements should not be read as guarantees of
future performance or results. Such statements involve known and
unknown risks, uncertainties and other factors that may cause actual
results, performance or achievements to be materially different from
those implied by such statements. Such factors include, but are
not limited to: our ability to identify and pursue growth, financing and
other strategic objectives, and the regulatory and economic environments
in the jurisdictions we operate or intend to operate or investment in.
Although such statements are based on management’s reasonable
assumptions at the date such statements are made, there can be no
assurance that the proposed acquisition will occur and that such
forward-looking information will prove to be accurate, as actual results
and future events could differ materially from those anticipated in such
forward-looking information. Accordingly, readers should not
place undue reliance on the forward-looking information. MJardin
assumes no responsibility to update or revise forward-looking
information to reflect new events or circumstances unless required by
applicable law.

Contacts

Media Contact:
Cory Ziskind
ICR
646-277-1232
cory.ziskind@icrinc.com

Investor Contact:
Ali Mahdavi
Capital Markets &
Investor Relations
416-962-3300
Ali.mahdavi@mjardin.com
or
Frank
Knuettel II, 720-613-4019
Chief Strategy Officer
Frank.Knuettel@MJardin.com